| Professional Home Health Care, Inc | |
| 4934 South Laurel Road, London, Kentucky 40744 | |
| (606) 864-0724 | |
| Name | Professional Home Health Care, Inc |
|---|---|
| Location | 4934 South Laurel Road, London, Kentucky |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 187146 |
| Ownership Type | Voluntary Non-profit - Private |
| Service Area Zip Codes | 40475, 40502, 40503, 40504, 40505, 40507, 40508, 40509, 40510, 40511, 40513, 40514, 40515, 40516, 40517, 40701, 40702, 40729, 40734, 40737, 40740, 40741, 40743, 40744, 40759, 40763, 40769, 40771, 40903, 40906, 40915, 40921, 40923, 40935, 40940, 40943, 40949, 40953, 40962, 40982, 40997 |
| Quality Rating: |
News Archive
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Allscripts announced today that Mountain States Health Alliance (MSHA) has selected the Allscripts Electronic Health Record (EHR) and Practice Management (PM) solutions for 300 employed and affiliated physicians and mid-level providers to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.
Stress, especially in women, is increasingly being recognized as a major risk factor for coronary heart disease, a condition in which blood vessels to the heart are blocked by plaque buildup or inflammation.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 99.6 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.7 | 98.6 |
| How often the home health team checked patients’ risk of falling | 100 | 99.6 |
| How often the home health team checked patients for depression | 97.5 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 59.7 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 55.8 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 99.8 | 96.4 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Allscripts announced today that Mountain States Health Alliance (MSHA) has selected the Allscripts Electronic Health Record (EHR) and Practice Management (PM) solutions for 300 employed and affiliated physicians and mid-level providers to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.
Stress, especially in women, is increasingly being recognized as a major risk factor for coronary heart disease, a condition in which blood vessels to the heart are blocked by plaque buildup or inflammation.
› Verified 6 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 74 | 79.6 |
| How often patients got better at getting in and out of bed | 81.3 | 81.1 |
| How often patients got better at bathing | 67.5 | 82.3 |
| How often patients’ breathing improved | 56.5 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 90.6 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 66.2 | 75 |
| How often home health patients had to be admitted to the hospital | 17.2 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.8 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 98.9 | 94 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Allscripts announced today that Mountain States Health Alliance (MSHA) has selected the Allscripts Electronic Health Record (EHR) and Practice Management (PM) solutions for 300 employed and affiliated physicians and mid-level providers to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.
Stress, especially in women, is increasingly being recognized as a major risk factor for coronary heart disease, a condition in which blood vessels to the heart are blocked by plaque buildup or inflammation.
› Verified 6 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Allscripts announced today that Mountain States Health Alliance (MSHA) has selected the Allscripts Electronic Health Record (EHR) and Practice Management (PM) solutions for 300 employed and affiliated physicians and mid-level providers to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.
Stress, especially in women, is increasingly being recognized as a major risk factor for coronary heart disease, a condition in which blood vessels to the heart are blocked by plaque buildup or inflammation.
› Verified 6 days ago
The patient survey data of Professional Home Health Care, Inc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 89 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 86 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 78 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 83 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 74 | 78 |
News Archive
AVANIR Pharmaceuticals, Inc. today announced the electronic publication of the results of the pivotal Phase III STAR trial of its investigational drug AVP-923 (dextromethorphan/quinidine) in the Annals of Neurology. The publication entitled "Dextromethorphan Plus Ultra-Low-Dose Quinidine Reduces Pseudobulbar Affect" evaluated two low dose formulations compared to placebo in the treatment of pseudobulbar affect (PBA) in patients with underlying amyotrophic lateral sclerosis (ALS) or multiple sclerosis (MS).
Researchers in the Cardiovascular Innovation Institute, a partnership between the University of Louisville and Jewish Hospital, in collaboration with researchers at Indiana University and Purdue University, have received a $2,027,059 grant from the National Institutes of Health to further develop an implantable pump that could dramatically improve the lives of patients with single ventricle heart disease.
Allscripts announced today that Mountain States Health Alliance (MSHA) has selected the Allscripts Electronic Health Record (EHR) and Practice Management (PM) solutions for 300 employed and affiliated physicians and mid-level providers to enhance the quality of patient care, improve patient communications, and better manage the cost of care delivery.
Stress, especially in women, is increasingly being recognized as a major risk factor for coronary heart disease, a condition in which blood vessels to the heart are blocked by plaque buildup or inflammation.
› Verified 6 days ago
Vna Health At Home 1 Location: 740 East Laurel Road, London, Kentucky 40741 Ratings: Phone: (606) 877-3950 | |
Professional Home Health Care, Inc Location: 4934 South Laurel Road, London, Kentucky 40744 Ratings: Phone: (606) 864-0724 |